CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced Revolution RT,i a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.

芝加哥--（商业新闻短讯）--GE HealthCare（纳斯达克：GEHC）今天宣布了Revolution RT，i，一种新的放射治疗计算机断层扫描（CT）解决方案，具有创新的硬件和软件解决方案，有助于提高成像准确性，同时简化模拟工作流程，为临床医生和患者提供更个性化和无缝的肿瘤护理路径体验。

The new Revolution RT is being unveiled at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress in Glasgow, along with an updated and artificial intelligence (AI)-enhanced version of the Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic magnetic resonance imaging (MRI) Planner.

在格拉斯哥举行的2024年欧洲放射治疗与肿瘤学会（ESTRO）大会上，新一代放射治疗技术（RT）与智能放射治疗（iRT）平台的更新版和人工智能（AI）增强版一起亮相，该平台与光谱磁共振成像（MRI）计划者接口。

Additionally, the company will showcase the newly acquired MIM Software portfolio, as well as other key innovations from GE HealthCare..

此外，该公司将展示新收购的MIM软件组合，以及GE HealthCare的其他关键创新。。

One of the biggest challenges of oncology care is the complexity of the disease — both in the many varieties of cancer, and the disparate ways it can present in each individual patientii — requiring diligence and personalization in diagnosis and treatment. Additionally, treatment often requires the expertise of multiple disciplines and experts related to specific organs and systems in the body, resulting in potential delays to diagnosis and timely treatment.

肿瘤学护理面临的最大挑战之一是该疾病的复杂性-无论是在多种癌症中，还是在每个患者中都可能出现不同的方式-需要在诊断和治疗中勤奋和个性化。此外，治疗通常需要与身体特定器官和系统相关的多学科和专家的专业知识，从而可能延误诊断和及时治疗。

According to research published by the British Medical Journal (BMJ), the mortality risk increases 6-13% for every month a diagnosis is delayediii, therefore, it is critical to streamline the complex oncology care pathway and reduce the time from diagnosis to treatment, ultimately leading to improved patient outcomes..

根据英国医学杂志（BMJ）发表的研究，诊断延迟的每个月的死亡风险增加6-13%，因此，简化复杂的肿瘤护理途径并减少从诊断到治疗的时间至关重要，最终导致患者预后的改善。。

“At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-driven technologies that transform and optimize the care continuum,” said Dr. Taha Kass-Hout, chief technology and science officer of GE HealthCare. “Our showcase at ESTRO this year highlights innovations that will allow clinicians to view the patient’s anatomy with great accuracy, helping facilitate precise tumor targeting while aiming to protect nearby healthy tissue.

GE HealthCare首席技术和科学官塔哈·卡斯·霍特（Taha Kass Hout）博士表示：“在GE HealthCare，我们致力于通过AI驱动的技术来推动肿瘤治疗的前沿，这些技术可以改变和优化护理连续性。”。“我们今年在ESTRO的展示突出了一些创新，这些创新将使临床医生能够非常准确地查看患者的解剖结构，有助于促进精确的肿瘤靶向，同时旨在保护附近的健康组织。

By integrating these capabilities into our systems, we create a precise, more connected, and efficient care environment that accelerates the delivery of personalized and timely care, with the goal of enabling better patient outcomes. This comprehensive approach empowers clinicians around the globe to tackle the most challenging disease states with precision and efficiency.”.

通过将这些功能集成到我们的系统中，我们创造了一个精确，更互联，更高效的护理环境，加速了个性化和及时护理的提供，目标是实现更好的患者结果。这种全面的方法使全球临床医生能够精确有效地应对最具挑战性的疾病状态。”。

GE HealthCare’s novel radiation therapy solutions, and recent acquisition of the MIM Software portfolio, are designed to reshape the oncology experience around the needs of providers and their patients across the cancer care continuum:

GE HealthCare的新型放射治疗解决方案，以及最近收购的MIM软件组合，旨在围绕癌症护理连续体中提供者及其患者的需求重塑肿瘤学体验：

Introducing Revolution RT

引入Revolution RT

As healthcare systems around the world experience growing volumes of radiation therapy (RT) patients, providers are looking for a CT simulator that enables precision simulation while reducing workflow complexity, with the goal of expediated patient care.iv

随着世界各地的医疗保健系统经历了越来越多的放射治疗（RT）患者，提供者正在寻找一种CT模拟器，该模拟器可以实现精确模拟，同时降低工作流程的复杂性，目标是快速护理患者

GE HealthCare designed its new Revolution RTi with a wide-bore CT platform and high-performance radiation therapy simulation, diagnostic, and interventional capabilities to accommodate more patients, and create a more streamlined standard of care. Revolution RT includes precision radiotherapy simulation that will help enable more accurate imaging, while improving workflow and efficiency, and using deep learning technology to help image the patient with accuracy..

GE HealthCare通过大口径CT平台和高性能放射治疗模拟、诊断和介入功能设计了其新革命RTi，以容纳更多患者，并创建更简化的护理标准。Revolution RT包括精确的放射治疗模拟，这将有助于实现更准确的成像，同时改进工作流程和效率，并使用深度学习技术帮助准确成像患者。。

Updated Intelligent Radiation Therapy (iRT)

更新的智能放射治疗（iRT）

At ESTRO 2024, GE HealthCare will also be showcasing the newly updated iRT platform, which was originally launched at ESTRO 2023. This innovative solution enables greater interoperability, connectivity, and efficiency throughout the entirety of the radiation oncology care continuum and includes key features such as an integrated workflow that connects various applications into an intuitive single interface, multi-vendor interoperability, seamless data transfer and task automation, and a catalog of RT applications from both GE HealthCare and third parties..

在ESTRO 2024上，GE HealthCare还将展示最新更新的iRT平台，该平台最初是在ESTRO 2023上推出的。这一创新解决方案在整个放射肿瘤学护理连续体中实现了更高的互操作性、连通性和效率，并包括关键功能，例如将各种应用程序连接到直观的单一界面的集成工作流、多供应商互操作性、无缝数据传输和任务自动化，以及GE HealthCare和第三方的RT应用程序目录。。

The company is unveiling multiple updates to the iRT platform, which highlight its vendor-agnostic ecosystem:

该公司推出了iRT平台的多项更新，突出了其供应商不可知的生态系统：

MR Direct (with Spectronic Medical): Spectronic Medical’s application, which is integrated into the updated iRT, uses AI to convert MR simulation images into an equivalent CT image that can be used for RT dose calculation.

MR Direct（与Spectronic Medical）：Spectronic Medical的应用程序集成到更新的iRT中，使用AI将MR模拟图像转换为可用于RT剂量计算的等效CT图像。

Simplified Planning (with MIM): Advance interoperability with automated context launching to simplify pre-treatment planning steps including image viewing, segmentation, and fusion.

简化计划（使用MIM）：提高与自动上下文启动的互操作性，以简化预处理计划步骤，包括图像查看，分割和融合。

InstaPlan (with RaySearch): A novel approach to treatment plan creation while the patient is still on the simulation table. This is a paradigm shift that can potentially reduce the time between simulation and first radiation dose. GE HealthCare’s collaboration with RaySearch will bring further innovation in simulation and treatment planning workflows to support advancements in Photon, Electron, Particle, and Brachy therapies..

InstaPlan（使用RaySearch）：一种在患者仍在模拟表上时创建治疗计划的新方法。这是一种范式转变，可能会减少模拟与第一次辐射剂量之间的时间。GE HealthCare与RaySearch的合作将在模拟和治疗计划工作流程方面带来进一步创新，以支持光子、电子、粒子和近距离治疗的进步。。

Personalization: The newly enhanced version of iRT is updated to allow user-enabled personalization, analytics, and notification modules.

个性化：更新了iRT的新增强版本，以允许用户启用个性化、分析和通知模块。

“The key to better patient outcomes in oncology care requires solutions that simplify and shorten an incredibly complex workflow for providers, as well as personalize the care pathway for patients, in order to ensure more effective care for each individual,” said Dr. Ben Newton, general manager, Oncology at GE HealthCare.

GE HealthCare肿瘤学总经理Ben Newton博士说：“在肿瘤学护理中，改善患者预后的关键在于简化和缩短提供者极其复杂的工作流程，以及个性化患者护理路径，以确保为每个人提供更有效的护理。”。

“GE HealthCare worked closely with clinicians globally to develop the iRT platform which streamlines the radiation therapy pathway by connecting disparate multi-vendor application systems, creating a vendor-agnostic ecosystem and harnessing the power of AI to potentially reduce the critical time between treatment planning and first treatment.”.

“GE HealthCare与全球临床医生密切合作，开发iRT平台，该平台通过连接不同的多供应商应用系统，创建一个供应商不可知的生态系统，并利用人工智能的力量来减少治疗计划和首次治疗之间的关键时间，从而简化放射治疗途径。”。

Advancing AI and Digital Solutions for More Personalized Oncology Radiation Therapy

推进AI和数字解决方案以实现更个性化的肿瘤放射治疗

GE HealthCare recently announced the acquisition close of MIM Software and the addition of its imaging analytics and digital workflow offerings as a part of the company’s portfolio. MIM Software's clinical tools – paired with GE HealthCare's imaging solutions – bring improved flexibility, automation, and efficiency to providers.

GE HealthCare最近宣布收购MIM软件，并将其成像分析和数字工作流程产品作为公司投资组合的一部分。MIM软件的临床工具与GE HealthCare的成像解决方案相结合，为供应商带来了改进的灵活性、自动化和效率。

This includes the addition of MIM Software’s radiation oncology portfolio, which is designed to provide clinicians with complementary interoperable solutions that can help simplify complex planning and deliver faster treatment..

这包括增加MIM软件的放射肿瘤学组合，该组合旨在为临床医生提供互补的互操作解决方案，有助于简化复杂的计划并提供更快的治疗。。

Additionally, the MIM acquisition enabled the expansion of GE HealthCare’s relationship with Elekta, a leader in precision radiation oncology. GE HealthCare’s MIM Software portfolio will enhance Elekta’s innovative treatment planning software which aids in the delivery of radiation therapy through enabling precision dose calculation.

此外，MIM的收购扩大了GE HealthCare与精准放射肿瘤学领导者Elekta的关系。GE HealthCare的MIM软件组合将增强Elekta的创新治疗计划软件，该软件通过实现精确的剂量计算来帮助提供放射治疗。

The collaboration is expected to harness MIM Software and Elekta’s respective strengths in regional markets to make solutions available globally..

预计此次合作将利用MIM软件和Elekta在区域市场的各自优势，在全球范围内提供解决方案。。

This news complements GE HealthCare and Elekta’s existing global collaboration agreement, which enables the two companies to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy.

这一消息补充了GE HealthCare和Elekta现有的全球合作协议，使两家公司能够为需要放射治疗的癌症患者提供全面的成像和治疗服务。

To learn more about GE HealthCare’s latest innovations within oncology care, please visit the ESTRO 2024 Congress booth #220 in Glasgow from May 3-7 or visit the website here.

要了解更多有关GE HealthCare在肿瘤护理领域的最新创新，请于5月3日至7日访问位于格拉斯哥的ESTRO 2024 Congress booth#220或访问此处的网站。

About GE HealthCare Technologies Inc.

关于GE HealthCare Technologies Inc。

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.

GE HealthCare是全球领先的医疗技术、药物诊断和数字解决方案创新者，致力于提供集成的解决方案、服务和数据分析，使医院更高效、临床医生更有效、治疗更精确，患者更健康、更快乐。

Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring.

GE HealthCare为患者和提供者服务了125多年，正在推进个性化、互联化和富有同情心的护理，同时简化患者跨越护理路径的旅程。我们的成像、超声波、患者护理解决方案和药物诊断业务共同帮助改善患者护理，从诊断到治疗再到监测。

We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits..

我们是一家价值196亿美元的企业，拥有约51000名员工，致力于创造一个医疗保健无限的世界。。

Follow us on LinkedIn, X (formerly Twitter), Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information.

在LinkedIn、X（前Twitter）、Facebook、Instagram和Insights上关注我们的最新消息，或访问我们的网站https://www.gehealthcare.com/了解更多信息。

_________________________

_________________________

i This product is not CE Marked and cannot be placed on the market or put into service until it has been made to comply with CE marking.

i本产品未经CE标记，在符合CE标记之前，不得投放市场或投入使用。

ii American Association for Cancer Research. Complexities of Cancer Explained for Patient Benefit. Available at: https://www.aacr.org/blog/2015/05/26/complexities-of-cancer-explained-for-patient-benefit/#:~:text=One%20of%20the%20biggest%20complexities,organs%20often%20behave%20very%20differently . Last accessed February 2023..

ii美国癌症研究协会。癌症的复杂性解释了患者的利益。网址：https://www.aacr.org/blog/2015/05/26/complexities-of-cancer-explained-for-patient-benefit/#:~：text=1%20最大的%20复杂性，器官通常表现出非常不同的行为。上次访问时间为2023年2月。。

iii T. P. Hanna, W. D. King, S. Thibodeau, M. Jalink, G. A. Paulin, E. Harvey-Jones, D. E. O’Sullivan, C. M. Booth, R. Sullivan, A. Aggarwal. Mortality due to cancer treatment delay: systematic review and meta-analysis. The BMJ. DOI: 10.1136/bmj.m4087

iii T.P.Hanna、W.D.King、S.Thibodeau、M.Jalink、G.A.Paulin、E.Harvey Jones、D.E.O'Sullivan、C.M.Booth、R.Sullivan、A.Aggarwal。癌症治疗延迟导致的死亡率：系统评价和荟萃分析。BMJ。DOI:10.1136/bmj.m4087

iv CT Sub Segment Dashboard based on COCIR, Ispos, EMA, JP-KPI sources.

iv基于COCIR、ISPO、EMA、JP-KPI来源的CT细分市场仪表板。